Pine Bark Extract (Pycnogenol) for Blood Circulation

Strong evidence 20 studies

Research suggests that Pine Bark Extract (Pycnogenol) may support blood circulation, particularly in the context of chronic venous insufficiency, with multiple clinical studies and controlled trials reporting improvements in leg swelling, venous pressure, skin microcirculation, and oxidative stress markers compared to both placebo and compression stockings. The evidence base includes randomized controlled trials, registry studies, mechanistic research, and several reviews and meta-analyses, and the overall direction across this body of work is supportive, with proposed mechanisms including nitric oxide-mediated vascular relaxation, anti-inflammatory activity, antioxidant effects, and inhibition of platelet aggregation. However, the picture is not without complexity — a 2020 Cochrane-style systematic review rated the certainty of evidence across multiple conditions as very low due to small sample sizes, inconsistent outcome measures, and limited trial numbers, and a 2012 systematic review similarly concluded that available trials were too few and too varied to support firm conclusions for any single condition. On balance, the research is directionally promising, especially for venous circulation outcomes, but the evidence does not yet meet the threshold that would allow definitive conclusions, and larger, more rigorously designed trials are needed to confirm these findings.

Related studies

Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.

Title Type Year Direction Match
Improvements in edema and microcirculation in chronic venous insufficiency wi... Other 2024 Supports 92
Chronic venous insufficiency and venous microangiopathy: management with comp... Other 2019 Supports 92
Pycnogenol® in chronic venous insufficiency and related venous disorders. Review 2014 Supports 92
PYCNOGENOL in chronic venous insufficiency. RCT 2000 Supports 90
Pycnogenol in chronic venous insufficiency. RCT 2000 Supports 90
Pycnogenol® relieves chronic venous insufficiency (CVI) in diabetics: a suppl... Other 2025 Supports 88
Pycnogenol(®) French maritime pine bark extract in randomized, double-blind, ... Review 2024 Supports 88
Endothelium-dependent vascular effects of Pycnogenol. Other 1998 Supports 88
Antioxidant activity and biologic properties of a procyanidin-rich extract fr... Review 1999 Supports 87
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. Other 2018 Supports 85
Pine bark extract reduces platelet aggregation. Other 2000 Supports 85
Pine bark (Pinus spp.) extract for treating chronic disorders. Meta-analysis 2020 Supports 82
Phlebotonics for venous insufficiency. Meta-analysis 2020 Supports 80
Pycnogenol® (extract of French maritime pine bark) for the treatment of chron... Systematic review 2012 Supports 80
Impact of Pycnogenol® Use in the Treatment of Patients With Lipedema: A Rando... Other 2025 Supports 78
Phlebotonics for venous insufficiency. Meta-analysis 2016 Supports 78
Phlebotonics for venous insufficiency. Meta-analysis 2005 Supports 78
Therapeutic potential of natural compounds in inflammation and chronic venous... Review 2019 Supports 75
Modulation of endothelial nitric oxide by plant-derived products. Review 2009 Supports 75
Pycnogenol for chronic venous insufficiency. Other 2011 Supports 70

← Back to Pine Bark Extract (Pycnogenol)

Medical Disclaimer: Noyemi provides information from published research for educational purposes only. This content is not medical advice and does not replace consultation with a qualified healthcare provider. Always consult your doctor before starting, stopping, or changing any supplement regimen, especially if you take medications or have existing health conditions.